Literature DB >> 24388116

Nanoparticles and the control of oral infections.

Robert P Allaker1, Kaveh Memarzadeh2.   

Abstract

The potential of antimicrobial nanoparticles to control oral infections is reviewed. Such particles can be classified as having a size no greater than 100 nm and are produced using traditional or more novel techniques. Exploitation of the toxic properties of nanoparticles to bacteria, fungi and viruses, in particular metals and metal oxides, as well as their incorporation into polymeric materials have increased markedly over the past decade. The potential of nanoparticles to control the formation of biofilms within the oral cavity, as a function of their biocidal, anti-adhesive and delivery capabilities, is now receiving close attention. Latest insights into the application of nanoparticles within this field, including their use in photodynamic therapy, will be reviewed. Possible approaches to alter biocompatibility and desired function will also be covered.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Anti-adhesive; Antimicrobial; Biofilm; Coatings; Nanoparticles; Oral infections

Mesh:

Substances:

Year:  2013        PMID: 24388116     DOI: 10.1016/j.ijantimicag.2013.11.002

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  22 in total

1.  Hydrolyzed Ce(IV) salts limit sucrose-dependent biofilm formation by Streptococcus mutans.

Authors:  Lopa Bhatt; Lin Chen; Jinglong Guo; Robert F Klie; Junhe Shi; Russell P Pesavento
Journal:  J Inorg Biochem       Date:  2020-01-11       Impact factor: 4.155

Review 2.  Nanosized Building Blocks for Customizing Novel Antibiofilm Approaches.

Authors:  A J Paula; H Koo
Journal:  J Dent Res       Date:  2016-11-19       Impact factor: 6.116

Review 3.  Therapeutic Strategies Targeting Cariogenic Biofilm Microenvironment.

Authors:  Y Liu; Z Ren; G Hwang; H Koo
Journal:  Adv Dent Res       Date:  2018-02

4.  Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption.

Authors:  Pratap C Naha; Yuan Liu; Geelsu Hwang; Yue Huang; Sarah Gubara; Venkata Jonnakuti; Aurea Simon-Soro; Dongyeop Kim; Lizeng Gao; Hyun Koo; David P Cormode
Journal:  ACS Nano       Date:  2019-01-22       Impact factor: 15.881

5.  Dual antibacterial drug-loaded nanoparticles synergistically improve treatment of Streptococcus mutans biofilms.

Authors:  Kenneth R Sims; Julian P Maceren; Yuan Liu; Guilherme R Rocha; Hyun Koo; Danielle S W Benoit
Journal:  Acta Biomater       Date:  2020-08-25       Impact factor: 8.947

6.  Nanocatalysts promote Streptococcus mutans biofilm matrix degradation and enhance bacterial killing to suppress dental caries in vivo.

Authors:  Lizeng Gao; Yuan Liu; Dongyeop Kim; Yong Li; Geelsu Hwang; Pratap C Naha; David P Cormode; Hyun Koo
Journal:  Biomaterials       Date:  2016-06-02       Impact factor: 12.479

7.  Biosilver nanoparticle interface offers improved cell viability.

Authors:  Sarah Kay VanOosten; Esra Yuca; Banu Taktak Karaca; Kyle Boone; Malcolm L Snead; Paulette Spencer; Candan Tamerler
Journal:  Surf Innov       Date:  2016-11-07       Impact factor: 3.016

8.  Microbial mortality behavior promoted by silver (Ag+/Ago)-modified zeolite-rich tuffs for water disinfection.

Authors:  D Contreras-Arzate; M Islas-Espinoza; C Fall; D Alcántara-Díaz; M T Olguin; R López-Callejas; R Peña-Eguiluz
Journal:  J Environ Health Sci Eng       Date:  2020-07-05

9.  Antimicrobial Activity of Nanoparticle Calcium Hydroxide against Enterococcus Faecalis: An In Vitro Study.

Authors:  Omid Dianat; Sara Saedi; Majid Kazem; Mostafa Alam
Journal:  Iran Endod J       Date:  2014-12-24

10.  Combination of silver nanoparticles and Drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant Staphylococcus aureus.

Authors:  Marta Krychowiak; Mariusz Grinholc; Rafal Banasiuk; Miroslawa Krauze-Baranowska; Daniel Głód; Anna Kawiak; Aleksandra Królicka
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.